Phillip Isaacs

Boston Heart Diagnostics Corp. provides cardiovascular disease clinical services. It specializes in diagnostic testing, personalized treatment recommendations and personalized wellness programs. The company was founded by Bela F. Asztalos and Ernst J. Schaefer in 2007 and is headquartered in Framingham, MA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.

Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA.

CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018.

MuriGen Pty Ltd. discovers, develops and commercializes drugs. It develops drugs for cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy and thalassemia. The company was founded by Douglas James Hilton on September 28, 1999 and is headquartered in Melbourne, Australia.

Australis Biosciences operates as a boutique corporate advisory practice specializing in strategic advice. The firm serves in the area of healthcare, biotechnology and technology fields. The company is headquartered in Kew, Australia.

BioLigands ApS engages in research and experimental development on biotechnology. It develops and commercializes methods for the production of therapeutic products. The company was founded by Karsten Kristiansen, Lise Madsen, and Hongbin Zhang on April 18, 2002 and is headquartered in Odense, Denmark.

Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA.

Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA.

Strata Pathology Services, Inc. provides services for surgical pathology, cytology, molecular diagnostics and immune fluorescence. It also specializes in pathology and cytology as well as molecular diagnostics and immunoflorescence and provides laboratory services. The company was founded by Terence Harrist, Geoffrey Gottlieb and Robin Kirby in 1984 and is headquartered in Lexington, MA.

Life Technologies Australia Pty Ltd. is a biotechnology firm. The company is headquartered in Melbourne, Australia.

Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019.

Kinetic Diagnostics, Inc. provides precision medicine for athletes and fitness. The company was founded by James Valentine and Trisha Brown and is headquartered in Berkeley, CA.

Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.